Depression anxiety scale

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)